NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROFERON-A 170927 Pre Filled Syringes contains the active ingredient interferon alfa-2a (rbe) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Roferon-A pre-filled syringes. It does not contain all the available information. It does not take […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ONIVYDE Nanoliposomal irinotecan – Irinotecan 4.3 mg/mL concentrate for solution for infusion Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ONIVYDE. It does not contain all of the available information. All medicines have risks and […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. THIOPRINE 50 azathioprine film-coated tablets Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Thioprine 50. It does not contain all the available information. It does not take the place of talking to your doctor or […]
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska's research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2 targeting therapy in HER2-positive cancers. Removing […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LAMIVUDINE 150 MG + ZIDOVUDINE 300 MG ALPHAPHARM lamivudine and zidovudine CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you start LAMIVUDINE 150mg + ZIDOVUDINE 300mg Alphapharm. This leaflet answers some common questions about LAMIVUDINE 150mg […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CYTARABINE INJECTION Cytarabine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Cytarabine Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All […]
Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the long term. Main causes for NAFLD are our high-caloric diet in combination with a sedentary lifestyle. Hitherto, researchers have not fully understood the cause […]
PRINCETON, N.J.–(BUSINESS WIRE) January 22, 2021– Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg (injection for intravenous use) every two weeks or 480 mg every four weeks in combination with Cabometyx (cabozantinib) 40 mg once daily tablets was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment […]
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports. The retinal pigment epithelium (RPE), a layer of pigmented cells in the retina, functions […]
A team of scientists has shown that a key type of immune cell “self-renews” in humans. It is an unexpected discovery, as it was previously thought this specific type of “senescent” killer immune cell had reached “end-stage” and would die following one more stint at helping people fight off—or live with—certain infections. It suggests these […]
